Qiang X, Wen Q, Li J, Chen S, Tao T, Zhang H
Cancer Manag Res. 2025; 17():35-43.
PMID: 39816491
PMC: 11734501.
DOI: 10.2147/CMAR.S499043.
Mroczkowska A, Jazwiec B, Urbanska-Rakus J, Szymanowska S, Tessmann A, Pajak S
BMC Med Genomics. 2022; 15(1):20.
PMID: 35123463
PMC: 8818218.
DOI: 10.1186/s12920-022-01169-0.
Osman A, Deininger M
Blood Rev. 2021; 49:100825.
PMID: 33773846
PMC: 8563059.
DOI: 10.1016/j.blre.2021.100825.
Suttorp M, Millot F, Sembill S, Deutsch H, Metzler M
Cancers (Basel). 2021; 13(4).
PMID: 33672937
PMC: 7917817.
DOI: 10.3390/cancers13040798.
Neckles C, Sundara Rajan S, Caplen N
Wiley Interdiscip Rev RNA. 2019; 11(1):e1562.
PMID: 31407506
PMC: 6916338.
DOI: 10.1002/wrna.1562.
A Novel e8a2BCR-ABL1 Fusion Transcript without Insertion Sequence in a Patient with Chronic Myeloid Leukemia.
Jin C, Zhu X, Xiao M, Liu S, Liu X, Liu J
Ann Lab Med. 2017; 38(2):169-171.
PMID: 29214763
PMC: 5736678.
DOI: 10.3343/alm.2018.38.2.169.
Molecular techniques for the personalised management of patients with chronic myeloid leukaemia.
Alikian M, Gale R, Apperley J, Foroni L
Biomol Detect Quantif. 2017; 11:4-20.
PMID: 28331814
PMC: 5348117.
DOI: 10.1016/j.bdq.2017.01.001.
Novel BCR-ABL1 fusion and leukemic mutations of SETBP1, PAX5, and TP53 detected by next generation sequencing in chronic myeloid leukemia.
Fu S, Hu Y, Fu Y, Chen F, Liu X, Zhang M
Cancer Biol Ther. 2016; 17(10):1003-1009.
PMID: 27611742
PMC: 5079385.
DOI: 10.1080/15384047.2016.1219821.
A novel BCR-ABL1 fusion gene identified by next-generation sequencing in chronic myeloid leukemia.
Lyu X, Yang J, Wang X, Hu J, Liu B, Zhao Y
Mol Cytogenet. 2016; 9:47.
PMID: 27350795
PMC: 4922057.
DOI: 10.1186/s13039-016-0257-5.
ABL tyrosine kinases: evolution of function, regulation, and specificity.
Colicelli J
Sci Signal. 2010; 3(139):re6.
PMID: 20841568
PMC: 2954126.
DOI: 10.1126/scisignal.3139re6.
Major molecular response to imatinib in a patient with chronic myeloid leukemia expressing a novel form of e8a2 BCR-ABL transcript.
Tchirkov A, Couderc J, Perissel B, Goumy C, Regnier A, Uhrhammer N
Leukemia. 2005; 20(1):167-8.
PMID: 16270035
PMC: 1931492.
DOI: 10.1038/sj.leu.2404012.
